Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Composite MR Neuroimaging Marker for Alzheimer's Disease

Authors not listed

Medical College of Wisconsin · 2009

Abstract

The purpose of this study is to use a functional MRI (fMRI) index to compare the brain activity of healthy volunteers to that of people with mild cognitive impairment (MCI) and Alzheimer's disease. The ultimate goal is to develop an early diagnostic tool for Alzheimer's disease. The study hypotheses are: 1. The fMRI index will differentiate between Alzheimer's disease, non-Alzheimer's dementia, and healthy volunteers; 2. The fMRI index will distinguish participants with MCI who convert to Alzheimer's disease from those who convert to a non-Alzheimer's dementia and those who remain stable; 3. MCI participants with a lower fMRI index at baseline who convert will progress to Alzheimer's sooner than those with a higher fMRI index, and MCI participants with a faster rate of fMRI index decline who convert will have an earlier onset of Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2009). A Composite MR Neuroimaging Marker for Alzheimer's Disease. <em>Medical College of Wisconsin</em>. https://clinicaltrials.gov/study/NCT01615666
Vancouver
Anonymous. A Composite MR Neuroimaging Marker for Alzheimer's Disease. Medical College of Wisconsin. 2009.
BibTeX
@misc{anon2009ACompo, title = {A Composite MR Neuroimaging Marker for Alzheimer's Disease}, author = {Anonymous}, journal = {Medical College of Wisconsin}, year = {2009}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings